F. Barry Bays, Director at TREACE MEDICAL CONCEPTS, INC. (TMCI), sold 39,546 shares at $20.77 ($857K) on 2022-11-09, disclosed to the SEC on 2022-11-14.
Open-market sale of $857k TMCI by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.77 | 4,100 | $85K | 9.9% |
| 2 | $21.19 | 13,023 | $276K | 32.2% |
| 3 | $21.19 | 13,023 | $276K | 32.2% |
| 4 | $22.48 | 1,500 | $34K | 3.9% |
| 5 | $23.62 | 7,900 | $187K | 21.8% |
| Total | $21.68 avg | 39,546 |
| $857K |
| 100% |
| Filing → |
| TMCI | SELL | 2023-04-13 | $4.5M | — | Filing → |
| TMCI | SELL | 2023-03-30 | $3.0M | — | Filing → |
| TMCI | SELL | 2023-03-15 | $646K | — | Filing → |